This research aims to understand how cholecystectomy affects metabolic health and its potential long-term consequences.
Analysis of metabolic outcomes following cholecystectomy
Assessment of incidence rates of type 2 diabetes and obesity
Evaluation of cardiovascular disease risk factors
Cholecystectomy is associated with an increased risk of developing type 2 diabetes mellitus.
Patients often experience weight gain and obesity after the procedure.
Metabolic dysfunction-related liver disease and cardiovascular diseases are more prevalent post-surgery.
Abstract
Cholecystectomy can predispose to metabolic changes leading to type 2 diabetes mellitus, obesity, metabolic dysfunction-associated steatotic liver disease and cardiovascular diseases.